NeuroPace, Inc.
Price Action
Technical Summary
EMERGING TRENDNeuroPace, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 69), indicating performance broadly in line with the market. Earnings growth of 5% provides fundamental context to the price action. Investors should exercise caution due to high volatility (60% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $15.88 | +4.10% | ABOVE |
| 50 SMA | $16.38 | +0.91% | ABOVE |
| 100 SMA | $15.37 | +7.51% | ABOVE |
| 150 SMA | $15.64 | +5.69% | ABOVE |
| 200 SMA | $14.47 | +14.23% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NPCE in an uptrend right now?
NPCE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is NPCE overbought or oversold?
NPCE's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is NPCE outperforming the market?
NPCE has a Relative Strength (RS) Rating of 69 out of 99. NPCE is performing about average compared to the market.
Where is NPCE in its 52-week range?
NPCE is trading at $16.53, which is 84% of its 52-week high ($19.60) and 75% above its 52-week low ($7.56).
How volatile is NPCE?
NPCE has a Beta of 1.35 and 52-week volatility of 60%. It's more volatile than the S&P 500 - expect bigger swings.